Hong Kong

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:1000 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $620,000
  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)
  • Principal Investigator

    Honglin Chen
  • Research Location

    China
  • Lead Research Institution

    Hong Kong University
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Viral Vector / Nasal Flu construct with NS1 deletion. Includes the Receptor Binding Domain (RBD) of Covid-19 Preclinical proof of concept

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Functional Diversity of Serotonin Neurons in the Dorsal and Median Raphe Nuclei in Emotional Responses.

Early Fasting Serum Glucose or Weight Reduction With Tirzepatide and Metabolic Outcomes in People With Type 2 Diabetes: A Post Hoc Analysis of the SURPASS Trials.

Duality of Shehu transform with other well known transforms and application to fractional order differential equations.

A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity.

Effect of metformin in a novel experimental model of peripheral artery disease.

Water-directed pinning is key to tau prion formation.

Indoor climbing and well-being of young adults: Perspectives among indoor climbers.

DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial.

A core outcome set for acute otitis media (COS-AOM) for primary and community care studies.